A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

Clinical trial NCT07347548 · COMPLETED

Trial details

NCT number: NCT07347548
Sponsor: Grünenthal GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy (DMD)

Start date: 2026-01-06
Primary completion: 2026-06-09
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.